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Abstract - Most parameter ID methods use least squares criterion to fit parameter values to observed 
behavior. However, the least squares criterion can be heavily influenced by outlying data or un-modelled 
effects. In such cases, least squares estimation can yield poor results. Outlying data is often manually 
removed to avoid inaccurate outcomes, but this process is complex, tedious and operator dependent.  
This research presents an adaptation of the Levenberg-Marquardt (L-M) parameter identification method 
that effectively ignores least-square contributions from outlying data. The adapted method (aL-M) is 
capable of ignoring outlier data in accordance with the coefficient of variation of the residuals and was 
thus, capable of operator independent omission of outlier data using the 3 standard deviation rule. The aL-
M was compared to the original Levenberg-Marquardt (L-M) method in C-peptide, insulin and glucose 
data. In total three cases were tested: L-M in the full dataset, L-M in the same data where the points that 
were suspected to be affected by incomplete mixing at the depot site were removed, and the aL-M in the 
full data set.  
There were strong correlations between the aL-M and the reduced dataset from [0.85, 0.71] for the 
clinically valuable glucose parameters. In contrast, the unreduced data yielded poor residuals and poor 
correlations with the aL-M [0.44, 0.33]. The aL-M approach provided strong justification for consistent 
removal of data that was deemed to be affected by mixing.  
Keywords: Gly e ic modelling, l ast squares estimation, outlier data, numerical optimisation 
 
1. INTRODUCTION 
Parameter identification methods are used to determine 
optimal parameter values such that models can accurately 
capture some observed behaviour (Carson and Cobelli, 2001). 
Most parameter identification algorithms identify these 
parameter values by minimising a least squares 
objective/penalty function (Bard, 1970, Davidon, 1991, 
Docherty et al., 2012, Levenberg, 1944, Marquardt, 1963, 
Steihaug, 1983). This means doubling the distance of a data 
point from the modelled behaviour will lead to four times the 
influence from the objective function. 
This approach works well with most datasets, but is a cause of 
inaccurate parameter identification when outlying data is 
present (Sheiner and Beal, 1985). Outliers can cause least-
squares optimal parameter sets to diverge from an optimal 
parameter set defined by ‘inlying’ data points. This issue is 
overcome by performing inverse problems over a number of 
observations, determining the variance of the residuals, then 
defining points outside 3 standard deviations from simulated 
behaviour to be outliers and omitting them from subsequent 
iterations (Pukelsheim, 1994, Bakar et al., 2006). This process 
is time-consuming and can lead to ambiguous outcomes and 
diminished operator independence.  
We previously presented an adaption of the Gauss-Newton 
gradient-descent parameter identification method that reduces 
the contribution of outliers to the inverse problem (Gray et al., 
2016). Subsequently, this adaptation was compared with a 
typical approach through modelling a cohort of C-peptide and 
insulin data and showed that the adapted method can capture 
model parameters obscured by outlier points (Docherty et al., 
2014). This analysis compares very similar methods with the 
addition of glucose modelling, and also compares the adapted 
method to the typical method where the main unmodelled 
outlier data has been manually removed in all datasets.  
2. METHODS 
2.1 Clinical Protocol 
This analysis used data from a dietary intervention study that 
measured the effect of dietary fibre in females at risk of 
developing type 2 diabetes. The outcomes of the trial were 
presented by TeMorenga et al. (2010). Eighty-three 
individuals underwent the DISST (Lotz et al., 2010) at weeks 
0, 12, and 24. Some participants did not attend followup 
appointments and a total of 218 DISST procedures were 
undertaken. 
Participants fasted from 10 p.m. the night before the test and 
attended the clinic in the morning. During the test, participants 
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sat in a relaxed position. They had a cannula placed in their 
antecubital-fossa to administer glucose and insulin boluses, 
and draw blood samples. This ultimately led to high local 
depot concentrations of insulin and glucose after 
administration. A 10 g glucose bolus (50% dextrose) was 
administered at 6 minutes, and a bolus of actrapid insulin was 
administered at 6 minutes. Blood samples were taken at t = 0, 
5, 10, 15, 20, 25, 30, 35, 40, and 50 minutes. Glucose was 
measured at the bedside (Enzymatic glucose hexokinase assay, 
Abbot Labs, Illinois, USA), and samples were then spun and 
frozen for batch assays of insulin and C-peptide (ELISA 
Immunoassay, Roche, Germany).  
2.2 DISST Model 
The DISST model defines glucose, insulin, and C-peptide 
kinetics (Lotz et al., 2010). The models are defined: 
?̇?𝐶 = 𝑘𝑘2𝑌𝑌 − (𝑘𝑘1 + 𝑘𝑘3)𝐶𝐶 + 𝑈𝑈𝑁𝑁 (1) 
?̇?𝑌 = 𝑘𝑘1𝐶𝐶 − 𝑘𝑘2𝑌𝑌  (2) 
𝑈𝑈𝑁𝑁 = 𝑈𝑈𝐵𝐵 + 𝑈𝑈1(𝑡𝑡) + 𝑈𝑈2(𝑡𝑡) + 𝑈𝑈3(𝑡𝑡) (1𝑎𝑎) 
𝑈𝑈B = 𝑘𝑘3𝐶𝐶0 (1𝑏𝑏) 
𝑈𝑈1(𝑡𝑡) =  {
𝜃𝜃1, 𝑡𝑡 = 6
0, 𝑜𝑜𝑡𝑡ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 
(1𝑐𝑐) 
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where: 𝑈𝑈𝑁𝑁 is the endogenous insulin production comprised of 
the basal rate (𝑈𝑈𝐵𝐵), and first and second phases of insulin 
release (𝑈𝑈1−3) (pmol∙L-1∙min-1); 𝑈𝑈𝑋𝑋 is the exogenous insulin 
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(pmol∙L-1); 𝑌𝑌 is the interstitial C-peptide concentration 
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interstitial insulin concentration (mU∙L-1); 𝐺𝐺 is the blood 
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dose (g∙min-1) 𝑉𝑉𝑃𝑃 is the plasma insulin distribution volume (L); 
𝑉𝑉𝑄𝑄 is the interstitial insulin distribution volume (L); 𝑘𝑘1−3 are 
the C-peptide kinetic parameters (min-1); 𝑛𝑛𝐼𝐼 is the plasma-
interstitial diffusion rate (L∙min-1); 𝑛𝑛𝐶𝐶 is the interstitial insulin 
degradation rate (min-1); 𝑝𝑝𝐺𝐺  is the non-insulin mediated 
glucose disposal rate (min-1).  
𝜃𝜃1−7 are the lumped parameters identified in this analysis. 𝜃𝜃1 
is the first phase insulin release, 𝜃𝜃2 and 𝜃𝜃3 are the start and 
finish of the second phase insulin release, respectively. 𝜃𝜃4 is a 
combined metric for renal and hepatic insulin clearance. 𝜃𝜃5  is 
equal to 1 minus the first pass hepatic extraction of insulin. 𝜃𝜃6 
is the insulin sensitivity of the subject and is the key metric of 
clinical interest. 𝜃𝜃7 is the inverse of the glucose distribution 
volume. The remaining parameters from (1) and (2) were 
determined a-priori via the methods of Van Cauter et al. (Lotz 
et al., 2010, Van Cauter et al., 1992). 
2.3 Parameter identification methods 
This analysis compares the outcomes of the adapted 
Levenberg-Marquardt method (aL-M) with the original 
approach (L-M). The original Levenberg-Marquardt 
parameter identification approach iterates towards the optimal 
parameter set (𝛉𝛉𝒐𝒐𝒐𝒐𝒐𝒐) with the iterative process: 
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and 𝐉𝐉 is a Jacobian, 𝛙𝛙 is the residual vector, 𝑋𝑋 is the measured 
property; 𝑗𝑗 is the sample index from 1 up to the number of 
samples (m, 𝑗𝑗 = 1..m); 𝑋𝑋(𝛉𝛉𝒊𝒊, 𝑡𝑡𝑗𝑗) is the simulated value of 𝑋𝑋 at 
𝑡𝑡 = 𝑡𝑡𝑗𝑗; and 𝑋𝑋𝑀𝑀,𝑗𝑗 is the measured value of 𝑋𝑋 at 𝑡𝑡 = 𝑡𝑡𝑗𝑗. The 
damping term 𝜆𝜆 scales based on the Jacobian value. In contrast 
to typical implementation of L-M, 𝜆𝜆 is set as a constant in this 
analysis. This sacrificed some convergence speed but enabled 
more stable and consistent iteration. 
The aL-M was designed to dissipate the contribution of 
outlying data on the identification of  𝛉𝛉𝒐𝒐𝒐𝒐𝒐𝒐. The Gauss-Newton 
method defines the optimal direction, given by the combined 
Jacobian terms ((𝐉𝐉𝐓𝐓𝐉𝐉)−1𝐉𝐉𝐓𝐓), for reducing residuals of each data 
point, for each parameter. These direction vectors are 
multiplied by the residual matrix to determine the ideal 
direction for convergence. The adapted method modulates the 
effect of the residual vector by the residuals, but still uses the 
Jacobian in (6a). This contrasts with other robust estimation 
methods which use the long-established class of M-estimators 
(Farcomeni and Ventura, 2012, Banaś and Ligas, 2014). 
Hence, the adapted method reduces the effect of outliers on 𝛙𝛙 
in (6), while inheriting the robustness properties of Gauss-
Newton, substituting 𝛙𝛙 for ?̂?𝛙:  
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𝛉𝛉𝑖𝑖+1 = 𝛉𝛉𝑖𝑖 − (𝐉𝐉𝐓𝐓𝐉𝐉 + 𝜆𝜆 ∙ 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑(𝐉𝐉𝐓𝐓𝐉𝐉))−1𝐉𝐉𝐓𝐓?̂?𝛙 (7) 
where: 




|𝜓𝜓𝑀𝑀| is the median of the absolute values of the residuals and 
𝛽𝛽 is a scaling factor that determines the width of the peak as a 
function of |𝜓𝜓𝑀𝑀|. In this analysis, 𝛽𝛽 = 3. This value provides 
maximal objective function contributions at 𝜓𝜓 = ±𝛽𝛽|𝜓𝜓𝑀𝑀|, 
shown in Fig. 1. In contrast, the objective surface of typical 
Gauss-Newton minimises least-squares residuals and thus 
follows 𝜓𝜓2 as 𝜓𝜓 increases. The choice of 𝛽𝛽 significantly down-
weights outlier data over three standard deviations, in 
accordance with accepted statistics for rejection (Pukelsheim, 
1994, Bakar et al., 2006). 
 
Fig. 1. Objective contributions from (6) and (7). 
Three identification approaches were used to identify 𝛉𝛉: L-M 
with the full dataset (L-Mf), L-M with a down-sampled dataset 
(L-Mds), and the aL-M with the full dataset. First, the L-M and 
aL-M approaches were used to identify the parameter set 𝛉𝛉 =
[𝜃𝜃1, 𝜃𝜃2, 𝜃𝜃3]𝑇𝑇, to determine the contributions to 𝑈𝑈𝑁𝑁 using the C-
peptide data. This generated two sets of 𝑈𝑈𝑁𝑁 profiles and two 
sets of residuals for each DISST trial. The 𝑈𝑈𝑁𝑁 profiles were 
then used to identify the insulinaemic pharmaco-kinetic 
parameters 𝛉𝛉 = [𝜃𝜃4, 𝜃𝜃5]𝑇𝑇. The UN profile determined via the 
aL-M methodology was used for the aL-M estimation in the 
full insulin dataset. The UN profile determined using L-M was 
used to identify the insulinaemic parameters using the L-M 
method, and the full insulin data set, then in a dataset that had 
the point 5 minutes after insulin administration manually 
removed. Finally, the modelled interstitial insulin 
concentration (𝑄𝑄(𝑡𝑡)) was used to identify 𝛉𝛉 = [𝜃𝜃6, 𝜃𝜃7]𝑇𝑇 using 
the glucose data. The aL-M derived 𝑄𝑄(𝑡𝑡) profile was used to 
identify glycaemic parameters with aL-M. The 𝑄𝑄(𝑡𝑡) profile 
from L-Mf was used to identify glucose parameters in the full 
data set. Finally, the 𝑄𝑄(𝑡𝑡) profile from the L-Mds was used to 
aid identification of glycaemic parameters in a dataset that had 
the glucose samples 5 and 10 minutes after glucose 
administration removed. Visual inspection showed that 
glucose had slower mixing behaviour than insulin.  
2.4 Evaluation 
The 3 approaches were assessed qualitatively based on the 
model residuals. Since the typical approach minimises ‖𝛙𝛙‖2 
and the adapted approach minimises ‖?̂?𝛙‖2, the methods 
cannot be quantitatively compared. To highlight the 
differences in the approach outcomes, both summary statistics 
of absolute 𝜓𝜓 values and residuals as a function of time (𝜓𝜓(𝑡𝑡)) 
will be presented. 
3. RESULTS 
Correlations between the methods are presented in Table 1. 
Samples at 𝑡𝑡 = 20 minutes for insulin, and 𝑡𝑡 =10, 15 minutes 
for glucose were removed from the datasets to form the 
‘downsampled’ parameter identification set. The adapted 
results correlated well to the downsampled glucose 
parameters, but were not so well correlated for the insulin 
parameters.  
Table 1. Summary statistics of parameter correlations 
Set 1 Set 2 Parameter Correlations  
L-Mf aL-M [0.96, 0.92, 0.91, 0.44, 0.08, 0.44, 0.33] 
L-Mds aL-M [0.96, 0.92, 0.91, 0.27, 0.26, 0.85, 0.71]  
L-Mds L-Mf [1.00, 1.00, 1.00, 0.21, 0.11, 0.68, 0.15] 
Summary statistics of the absolute residual data are presented 
in Table 2. This residual data was not moderated by equation 
7a in any case, indicating a discordance across the objective 
function and residuals recorded for the aL-M.  
Fig. 2 shows a set of responses in which outliers appear at the 
locations where the residuals are biased. Fig. 3 shows the 
distribution of the residuals about the measured points (𝛙𝛙). C-
peptide samples are relatively well centred about zero and 
follow a seemingly normal distribution. In contrast, both the 
insulin and glucose residuals were sporadic, showing biases 
during the mixing phases at 𝑡𝑡=20 minutes for insulin, and 𝑡𝑡=10 
minutes for glucose. 
4. DISCUSSION 
The adaptation to the Levenberg-Marquardt parameter 
identification method yielded different results to the typical 
approach. By minimising a residual that represents a majority 
of the datapoints and mitigating the contribution from outliers, 
the adapted method produced residuals that were qualitatively 
different from the original method (Figs. 2 and 3). The residual 
curves of the aL-M approach resembled those of the L-Mds, 
which identified parameters in data wherein the most common 
outliers had been removed.  




     
The adapted method performs similarly to the original 
approach in noisy data that does not contain outliers, providing 
no benefit nor deleterious outcomes. However, when data 
contains known outliers, the adapted method considerably 
improves identification. The correlations in C-peptide 
parameters 𝜃𝜃1−3 were between 0.91 and 0.96 (Table 1). These 
high correlations occurred as the C-peptide data contained 
measurement noise but no significant outliers, and the adapted 
method varied minimally from the original approach.  
However, the insulin and glucose data both had un-modelled 
mixing behaviour that led to outlying data. This caused 
significant divergence in parameter values obtained (R=0.08 – 
0.44 for the insulin parameters, and R=0.33 – 0.44 in glucose 
parameters). The aL-M method recognised the outlier points 
and minimised their contribution to convergence in the 
parameter space. Fig. 3 shows where biases occur in the 
models for the insulin and glucose data. In the insulin data, the 
original approach models the t = 20 minutes data point more 
accurately than the adapted approach. However, this data point 
is affected by incomplete mixing of insulin at the depot site, 
and is thus, an unmodelled phenomenon. Hence, this point was 
a consistent outlier in measured data, and an ideal fit for this 
data would not be influenced by this point. The adapted 
method increased the apparent residuals at the outlier data 
point in order to improve fit for the points that were well 
approximated by the model. Fig. 2 and Fig. 3 indicate 
performance of the aL-M was comparable to the manual 
removal of outliers undertaken in the L-Mds approach. 
The glucose data also benefits from the use of the adapted 
method, though not as much as the insulin. The first two 
datapoints have the most bias due to mixing at t = 10, 15 
minutes, and adapted method again decreases their 
contribution to the objective surface and follows the remaining 
datapoints closely. Table 1 shows that the aL-M method 
displays good correlation with the L-Mds method (R=0.85, 
R=0.71), compared to the original approach (R=0.44, R=0.33).  
The higher correlation was for insulin sensitivity, which is the 
primary metric of interests in glycaemic modelling (Ferrannini 
et al., 1997, Haffner et al., 1999, Bergman et al., 1979). 
This study considered applying a simple Gauss-Newton 
algorithm similar to the methods from Gray et al. (2016). 
However, this method was susceptible to instability when 
outliers were particularly severe in data. While adapted Gauss-
Newton was stable, the un-adapted method became unstable 
and led to extreme residuals for several trials, preventing 
proper comparisons. Hence, a simplified version of the 
Levenberg-Marquart algorithm was used. This required more 
iterations to converge, but allowed consistent and stable 
results.   
 
 
Table 2. Summary statistics of model residuals 
Model Approach Percentiles of Relative Residuals 
(as percentage of observed data) 





[0.55, 1.69, 3.62, 8.24, 13.6] 






[13.2, 34.8, 78.0, 304, 1219] 
[6.94, 17.4, 35.6, 100, 283] 






[0.86, 2.82, 5.54, 15.5, 31.3] 
[0.40, 1.52, 3.35, 12.4, 24.4] 
[0.28, 1.54, 4.52, 14.0, 28.7] 
 
Fig. 2. Plasma C-peptide, insulin, and glucose responses of a 
patient response to the DISST test with noticeable outliers in 
the insulin and glucose data.  
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(as percentage of observed data) 





[0.55, 1.69, 3.62, 8.24, 13.6] 






[13.2, 34.8, 78.0, 304, 1219] 
[6.94, 17.4, 35.6, 100, 283] 






[0.86, 2.82, 5.54, 15.5, 31.3] 
[0.40, 1.52, 3.35, 12.4, 24.4] 
[0.28, 1.54, 4.52, 14.0, 28.7] 
 
Fig. 2. Plasma C-peptide, insulin, and glucose responses of a 
patient response to the DISST test with noticeable outliers in 




     
C-peptide data did not benefit from the adaptive method 
overall. While the interquartile ranges remained similar, the 
extreme outliers out spread further, creating outlier residuals. 
This suggests the adapted method is not beneficial in every 
case, and that the nature of noise in the data should be 
considered before choosing to use the method. In particular, 
the method should be used when there are significant outliers 
or unmodelled effects. This may be due to the method relying 
on inlier datapoints meeting or exceeding the number of 
identified parameters. With three parameters to identify and 
random noise sometimes creating too many points that classify 
as outliers, the method may return a poor model, this could 
potentially be ameliorated by shifting to a 75th percentile 
residual in Eq. 7a rather than the median, 50th percentile. 
The adapted method is relatively simple to add to the 
parameter identification methods, and computationally 
inexpensive. The adapted method removes need for the manual 
removal of outlier data. Removing outlier data using other 
applications often requires two runs of the inverse problem: 
once to simulate a model, then again after datapoints that fall 
at more than three standard deviations from the model have 
been removed. This is costly in operator time, and risks 
reducing operator independence. 
The presence of outliers is often suspected a priori. In 
particular, outliers can be observed when recording data, or 
through plotting the data before initiating parameter 
identification. However, it can be difficult to determine which 
data points should be declared outliers with statistically 
justified scientific integrity. This analysis shows that removing 
  
Fig. 3. Residual plots for C-peptide, insulin, and glucose. The plots on the right are cropped to show the general behaviour. The 
thick error bars show the interquartile range, thin error bars show the 5th to 95th percentile range, and the dots show the outlying 
points. The time points are offset for L-Mds and aL-M to enable clearer observation. 
 




     
points directly after mixing is justified according to the 
operator independent aL-M algorithm that automatically 
applies well-known statistical justification (Pukelsheim, 1994, 
Bakar et al., 2006). Further research could be performed to 
directly compare the adapted method with a downsampled 
method that does two runs of the inverse problem to properly 
remove outlier points.  
5.  CONCLUSIONS 
In this analysis we tested the aL-M method against a more 
typical Levenberg-Marquardt method where outliers were 
both kept in, and manually removed. The methods were tested 
for both noisy data that contained outliers and un-modelled 
effects, and data that were only noisy. The aL-M method 
captured observed behaviour better in data that contained un-
modelled effects or outlying data, performing similarly to the 
typical method following a manual removal of outliers. It 
provided minimal changes in identification to data that was 
just noisy.  
Overall, this analysis showed that the data immediately after 
bolus administration are consistently affected by unmodelled 
mixing. This paper provides a statistical justification for 
consistent removal of these points in accordance with the 3-
sigma rule outlier detection rule.  
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